Additional file 2 of Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment
收藏数据链接：
官方服务：
资源简介：
Additional file 2: Table S2. Compounds with an oral bioavailability value greater than 30%. Table S3. Compounds with a Caco-2 value > − 0.4. Table S4. Compounds with a drug-likeness value > 0.18. Table S5. Compound with a half-life > 3 h . Table S6. The potentially bioactive compounds of YGL capsule using the ADME in silico integrative model.
提供机构：
figshare创建时间：
2020-02-06
